Skip to main content
All lobbying clients

UCB, INC.

Lobbying client · Georgia · filed 2025 to 2026

Biopharmaceutical company dealing in severe diseases in immunology and neurology.

$4,610,000 Reported spend
29 Filings counted
3 Outside firms hired
17 Bills named

Spend is reported income plus in-house expenses across 29 filings. The LDA keeps a separate client record for every registrant that files for a client, so this page adds up 4 records, one per registrant listed below. Records are combined when the client name matches once case, punctuation and endings such as Inc. or LLC are set aside; for a city, county or port the state has to match as well.

 Who filed for this client 4

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

 Bills named in these filings 17
  • S. 864
    HELP Copays Act
    8 filings
  • H.R. 1
    One Big Beautiful Bill Act
    7 filings
  • H.R. 2423
    Unfair Tax Prevention Act
    5 filings
  • H.R. 591
    Defending American Jobs and Investment Act
    5 filings
  • H.R. 946
    ORPHAN Cures Act
    5 filings
  • H.R. 993
    Emerging Innovative Border Technologies Act
    3 filings
  • H.R. 4993
    Joe Fiandra Access to Home Infusion Act of 2025
    2 filings
  • S. 1862
    ORPHAN Cures Act
    2 filings
  • H.R. 10431
    U.S. Innovation and Global Competitiveness Act of 2026
    1 filing
  • H.R. 1189
    National Plan for Epilepsy Act
    1 filing
  • H.R. 1990
    American Innovation and R&D Competitiveness Act of 2025
    1 filing
  • H.R. 4317
    PBM Reform Act of 2025
    1 filing
  • H.R. 5509
    Safe Step Act
    1 filing
  • H.R. 6423
    HELP Copays Act
    1 filing
  • H.R. 7148
    Consolidated Appropriations Act, 2026
    1 filing
  • S. 2903
    Safe Step Act
    1 filing
  • S. 494
    National Plan for Epilepsy Act
    1 filing
 Reported by year 2 years
  • 2026 $2,240,000 12 filings
  • 2025 $2,370,000 17 filings
 Issues lobbied 6

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 11
  • HOUSE OF REPRESENTATIVES 26
  • SENATE 25
  • Commerce, Dept of (DOC) 9
  • U.S. Trade Representative (USTR) 8
  • Treasury, Dept of 6
  • White House Office 6
  • Executive Office of the President (EOP) 5
  • Centers For Medicare and Medicaid Services (CMS) 4
  • Office of Management & Budget (OMB) 4
  • Intl Trade Administration (ITA) 1
  • Office of the Vice President of the United States 1
 Recent filings 29 total
Q3 report
VENN STRATEGIES
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $80,000 income · posted Oct 20, 2026
View → Q3 report
AKIN GUMP STRAUSS HAUER & FELD
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $80,000 income · posted Oct 20, 2026
View → Q3 report
UCB, INC.
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $360,000 expenses · posted Oct 19, 2026
View → Q3 report
THE NICKLES GROUP, LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $70,000 income · posted Oct 19, 2026
View → Q2 report
AKIN GUMP STRAUSS HAUER & FELD
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $80,000 income · posted Jul 20, 2026
View → Q2 report
UCB, INC.
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $710,000 expenses · posted Jul 17, 2026
View → Q2 report
VENN STRATEGIES
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $80,000 income · posted Jul 17, 2026
View → Q2 report
THE NICKLES GROUP, LLC
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $70,000 income · posted Jul 16, 2026
View → Q1 report
AKIN GUMP STRAUSS HAUER & FELD
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $80,000 income · posted Apr 20, 2026
View → Q1 report
UCB, INC.
1st Quarter 2026 (Jan 1 - Mar 31) · $520,000 expenses · posted Apr 17, 2026
View → Q1 report
THE NICKLES GROUP, LLC
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $70,000 income · posted Apr 16, 2026
View → Q1 report
VENN STRATEGIES
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $40,000 income · posted Apr 15, 2026
View → Q4 report
THE NICKLES GROUP, LLC
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $60,000 income · posted Jan 20, 2026
View → Q4 report
VENN STRATEGIES
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $80,000 income · posted Jan 20, 2026
View → Q4 report
AKIN GUMP STRAUSS HAUER & FELD
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $80,000 income · posted Jan 20, 2026
View → Q4 report
UCB, INC.
4th Quarter 2025 (Oct 1 - Dec 31) · House · $350,000 expenses · posted Jan 16, 2026
View → Q3 report
UCB, INC.
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $340,000 expenses · posted Oct 20, 2025
View → Q3 report
VENN STRATEGIES
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 20, 2025
View → Q3 report
AKIN GUMP STRAUSS HAUER & FELD
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $80,000 income · posted Oct 20, 2025
View → Q3 report
THE NICKLES GROUP, LLC
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 16, 2025
View →

Showing the 20 most recent of 29 filings. Search the explorer for "UCB, INC.".

 Foreign entities disclosed 1
  • UCB S.A Belgium named on 1 filing · highest disclosed ownership 100% · largest disclosed contribution $0

Section 7 of the LD-2: a foreign company or government that owns part of the client, pays toward the lobbying, or benefits from it. Figures are the highest single disclosure across these filings, not a sum: the same stake is re-disclosed each quarter.

Keep going

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem